Safety II Together: Coupling teaming science with patient engagement and health information transparency to coproduce diagnostic excellence
Safety II Together:将科学与患者参与和健康信息透明度结合起来,共同创造卓越的诊断
基本信息
- 批准号:10849649
- 负责人:
- 金额:$ 96.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2026-09-29
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Ambulatory diagnostic error is a vexing problem because events unfold across time with shifting team
members. Accurate and timely diagnosis relies on keeping patients and health care professionals (HCPs) on
the same page, both in and between clinic visits. Experts urge shared mental models (SMMs) of the diagnostic
process (DxP), because research shows their central role for effective team communication and coordination.
Yet little is known about how patients and HCPs develop and sustain SMMs, especially in the dynamic setting
of the DxP. While we have many examples of diagnostic errors in Safety-I research, there are few models of
“what good looks like” using a Safety-II lens. Since diagnostic excellence relies on factors and interactions
beyond any single HCP, progress will require identifying specific teaming behaviors that help patients and
HCPs to coproduce safety at known DxP risk points. We will close this foundational knowledge gap. We will
then develop and disseminate tools to support patients, care partners, interpreters and clinicians as active
contributors to the DxP through 3 partnering national organizations. In our current AHRQ grant, we learned that
patients have unique insights about the DxP, including identification of “diagnostic blindspots” – events or
conditions pertaining to DxP safety that HCPs or systems may not observe. These include events occurring
between visits, omissions, and misalignments stemming from lack of a SMM between patients and HCPs.
Interestingly, online access to visit notes (“open notes”) – now nearly universal through 2021 federal legislation
– may help development of SMMs because patients can gain context on HCP perspectives and potential gaps
in their understanding by reading notes. One sobering finding was that the most common contributing factor to
patient-reported diagnostic error was not feeling heard. Based on these data, we designed an online tool –
OurDX – to elicit patient priorities, histories, and potential concerns. We found that patients with limited English
proficiency (LEP) were 5x as likely to report not feeling heard, and older patients with poorer health were more
likely to identify a diagnostic blindspot. Teams that work need new approaches to share information, to listen,
and to respond, especially since harnessing the unique knowledge of each member (including early
identification of otherwise undetected blindspots) can increase system resilience. Our diagnostic center of
excellence – Safety2gether – is based on innovative and disciplined coupling of teaming science with patient
engagement to coproduce diagnostic safety, with a focus on safety-II principles and priority populations: LEP
and elderly patients with chronic illness and their care partners. Safety2gether will partner with patients, train
learners, define future research questions, foster collaborations, and share multistakeholder tools through 3
national organizations to both learn from, and serve as a resource for, other DCEs. Our team is specifically
curated with over a decade of expertise in teaming, diagnostic safety and patient engagement, and is uniquely
poised to help build safety equity through an evidence-based emphasis on listening and resilience.
门诊诊断错误是一个令人烦恼的问题,因为随着时间的推移,
成员准确和及时的诊断依赖于患者和医疗保健专业人员(HCP)保持
同一页,无论是在诊所访问和之间。专家敦促诊断的共享心理模型(SMM)
这是因为研究表明,他们在有效的团队沟通和协调中发挥着核心作用。
然而,关于患者和HCP如何发展和维持SMM,特别是在动态环境中,
关于DxP虽然我们在安全I研究中有许多诊断错误的例子,但很少有模型
“什么是好的样子”使用安全-II透镜。由于诊断的卓越性依赖于因素和相互作用
除了任何一个单一的HCP,进步将需要确定特定的团队行为,帮助患者,
HCP在已知DxP风险点共同产生安全性。我们将缩小这一基础知识差距。我们将
然后开发和传播工具,以支持患者、护理伙伴、口译员和临床医生积极参与
通过3个合作的国家组织为DxP做出贡献。在我们目前的AHRQ赠款中,我们了解到,
患者对DxP有独特的见解,包括识别“诊断盲点”-事件或
HCP或系统可能未遵守的与DxP安全性相关的条件。其中包括发生在
由于患者和HCP之间缺乏SMM而导致的访视、遗漏和不一致。
有趣的是,在线访问访问笔记(“开放笔记”)-现在几乎普遍通过2021年联邦立法
- 可能有助于SMM的开发,因为患者可以获得HCP观点和潜在差距的背景
通过阅读笔记来提高他们的理解力。一个发人深省的发现是,
患者报告的诊断错误感觉不到。基于这些数据,我们设计了一个在线工具-
OurDX -引出患者的优先事项、历史和潜在问题。我们发现英语水平有限的病人
熟练程度(LEP)的患者报告感觉不到被倾听的可能性是5倍,健康状况较差的老年患者更多
可能会发现诊断盲点工作的团队需要新的方法来分享信息,倾听,
并作出反应,特别是因为利用每个成员的独特知识(包括早期
否则未检测到的盲点的识别)可以增加系统弹性。我们的诊断中心
卓越-Safety 2gether-基于科学与患者合作的创新和纪律耦合
参与共同生产诊断安全,重点是安全II原则和优先人群:LEP
以及长期病患者和他们的护理伙伴。Safety 2gether将与患者合作,培训
学习者,定义未来的研究问题,促进合作,并通过3个共享多利益相关者工具
国家组织向其他地区选举委员会学习,并为其他地区选举委员会提供资源。我们的团队专门
在团队合作、诊断安全和患者参与方面拥有十多年的专业知识,
准备通过以证据为基础的重视倾听和复原力来帮助建立安全公平。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SIGALL BELL其他文献
SIGALL BELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SIGALL BELL', 18)}}的其他基金
Safety II Together: Coupling teaming science with patient engagement and health information transparency to coproduce diagnostic excellence
Safety II Together:将科学与患者参与和健康信息透明度结合起来,共同创造卓越的诊断
- 批准号:
10642466 - 财政年份:2022
- 资助金额:
$ 96.68万 - 项目类别:
Answering the call to engage patients and families in the diagnostic process: A new patient-centered approach using health information transparency to identify diagnostic breakdowns in ambulatory care
响应号召,让患者和家属参与诊断过程:一种以患者为中心的新方法,利用健康信息透明度来识别门诊护理中的诊断故障
- 批准号:
10254283 - 财政年份:2019
- 资助金额:
$ 96.68万 - 项目类别:
Answering the call to engage patients and families in the diagnostic process: A new patient-centered approach using health information transparency to identify diagnostic breakdowns in ambulatory care
响应号召,让患者和家属参与诊断过程:一种以患者为中心的新方法,利用健康信息透明度来识别门诊护理中的诊断故障
- 批准号:
10016291 - 财政年份:2019
- 资助金额:
$ 96.68万 - 项目类别:
相似国自然基金
药用植物华泽兰中改善II型糖尿病并发抑郁症活性先导化合物的挖掘及其作用机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
脂肪干细胞外泌体调节Bax/BAK1-caspase-3/caspase8信号轴影响II型肺泡上皮细胞衰老在脓毒症肺损伤中的作用及机制
- 批准号:MS25H010004
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
超长波长NIR-II 区有机探针的开发及在活体检测中的应用
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
αvβ3整合素靶向有机探针用于NIR-II FL/MRI双模态成像引导的三阴性乳腺癌光热治疗研究
- 批准号:2025JJ81013
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
全钒液流电池负极V(II)/V(III)电化学氧化还原的催化机理研究
- 批准号:2025JJ50094
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
1 类新药研发后补助(治疗用生物制品 1 类 MG-K10 人源化单抗注射液、II 期临床试验)
- 批准号:2025JK2095
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
1 类新药研发后补助(治疗用生物制品 1 类MG-ZG122 人源化单抗注射液、II 期临床试验)
- 批准号:2025JK2097
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
黏土矿物结构Fe(II)跨界面驱动氧化铁结合态有机质释放和转化机制
- 批准号:2025JJ50205
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
有序组装型NIR-II荧光探针的构建及疾病辅助诊断应用
- 批准号:2025JJ40014
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
NIR-II荧光内镜辅助胰腺癌术中肿瘤活性评估的可视化研究
- 批准号:2025JJ50653
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
LHCb Upgrade II: preconstruction for the ultimate LHC flavour physics experiment
LHCb 升级 II:终极 LHC 风味物理实验的预构建
- 批准号:
ST/X006484/1 - 财政年份:2024
- 资助金额:
$ 96.68万 - 项目类别:
Research Grant
SBIR Phase II: Innovative Two-Phase Cooling with Micro Closed Loop Pulsating Heat Pipes for High Power Density Electronics
SBIR 第二阶段:用于高功率密度电子产品的创新两相冷却微闭环脉动热管
- 批准号:
2321862 - 财政年份:2024
- 资助金额:
$ 96.68万 - 项目类别:
Cooperative Agreement
STTR Phase II: Fabrication and Structural Testing of a 3D Concrete Printed Anchor for Floating Offshore Wind
STTR 第二阶段:用于浮动海上风电的 3D 混凝土打印锚的制造和结构测试
- 批准号:
2333306 - 财政年份:2024
- 资助金额:
$ 96.68万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Innovative Glass Inspection for Advanced Semiconductor Packaging
SBIR 第二阶段:先进半导体封装的创新玻璃检测
- 批准号:
2335175 - 财政年份:2024
- 资助金额:
$ 96.68万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Intelligent Language Learning Environment
SBIR第二阶段:智能语言学习环境
- 批准号:
2335265 - 财政年份:2024
- 资助金额:
$ 96.68万 - 项目类别:
Cooperative Agreement
SBIR Phase II: FlashPCB Service Commercialization and AI Component Package Identification
SBIR第二阶段:FlashPCB服务商业化和AI组件封装识别
- 批准号:
2335464 - 财政年份:2024
- 资助金额:
$ 96.68万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Thermally-optimized power amplifiers for next-generation telecommunication and radar
SBIR 第二阶段:用于下一代电信和雷达的热优化功率放大器
- 批准号:
2335504 - 财政年份:2024
- 资助金额:
$ 96.68万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Sodium-Based Solid-State Batteries for Stationary Energy Storage
SBIR第二阶段:用于固定储能的钠基固态电池
- 批准号:
2331724 - 财政年份:2024
- 资助金额:
$ 96.68万 - 项目类别:
Cooperative Agreement
SBIR Phase II: A mesh-free, sling-free, minimally invasive treatment for stress urinary incontinence in women
SBIR II 期:无网、无吊带的微创治疗女性压力性尿失禁
- 批准号:
2233106 - 财政年份:2024
- 资助金额:
$ 96.68万 - 项目类别:
Cooperative Agreement
テーラーメード分子設計を利用したNIR-II有機色素の創製と分子機能開発
使用定制分子设计创建和开发 NIR-II 有机染料
- 批准号:
24KJ2124 - 财政年份:2024
- 资助金额:
$ 96.68万 - 项目类别:
Grant-in-Aid for JSPS Fellows